1. Home
  2. IMRN vs EEIQ Comparison

IMRN vs EEIQ Comparison

Compare IMRN & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • EEIQ
  • Stock Information
  • Founded
  • IMRN 1994
  • EEIQ 2017
  • Country
  • IMRN Australia
  • EEIQ United States
  • Employees
  • IMRN N/A
  • EEIQ N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • EEIQ Other Consumer Services
  • Sector
  • IMRN Health Care
  • EEIQ Real Estate
  • Exchange
  • IMRN Nasdaq
  • EEIQ Nasdaq
  • Market Cap
  • IMRN 9.2M
  • EEIQ 10.9M
  • IPO Year
  • IMRN N/A
  • EEIQ 2021
  • Fundamental
  • Price
  • IMRN $1.92
  • EEIQ $0.45
  • Analyst Decision
  • IMRN Strong Buy
  • EEIQ
  • Analyst Count
  • IMRN 1
  • EEIQ 0
  • Target Price
  • IMRN $5.00
  • EEIQ N/A
  • AVG Volume (30 Days)
  • IMRN 41.7K
  • EEIQ 1.4M
  • Earning Date
  • IMRN 08-29-2025
  • EEIQ 08-21-2025
  • Dividend Yield
  • IMRN N/A
  • EEIQ N/A
  • EPS Growth
  • IMRN N/A
  • EEIQ N/A
  • EPS
  • IMRN N/A
  • EEIQ N/A
  • Revenue
  • IMRN $4,777,422.00
  • EEIQ $9,358,301.00
  • Revenue This Year
  • IMRN N/A
  • EEIQ N/A
  • Revenue Next Year
  • IMRN N/A
  • EEIQ N/A
  • P/E Ratio
  • IMRN N/A
  • EEIQ N/A
  • Revenue Growth
  • IMRN 48.63
  • EEIQ 44.99
  • 52 Week Low
  • IMRN $1.50
  • EEIQ $0.42
  • 52 Week High
  • IMRN $2.87
  • EEIQ $1.74
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 56.80
  • EEIQ 41.94
  • Support Level
  • IMRN $1.85
  • EEIQ $0.45
  • Resistance Level
  • IMRN $1.94
  • EEIQ $0.50
  • Average True Range (ATR)
  • IMRN 0.08
  • EEIQ 0.04
  • MACD
  • IMRN 0.00
  • EEIQ -0.00
  • Stochastic Oscillator
  • IMRN 86.67
  • EEIQ 18.38

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.

Share on Social Networks: